“Reassuring” new data suggests cannabidiol (CBD) is safe and effective long-term treatment in Dravet syndrome, according to an Australian-led study. An extension of the GWPCARE trials showed that patients treated with oral liquid cannabidiol (Epidyolex) had sustained reductions in convulsive and total seizures, improved overall condition and no new adverse events at three-year follow-up. In ...
Cannabidiol effective in long term for treatment-resistant Dravet syndrome: Australian study
By Natasha Doyle
25 Aug 2021